Sera Prognostics, Inc. (SERA)
SERANASDAQ-GMMedical Specialities
$2.00
+0.0600 (+3.09%) today
Regular session, Nov 12, 10:15 AM ET
- Market cap
- $79.54m
- P/E
- –
- EPS, last 4 quarters
- $-0.6700
- Dividend yield
- –
- Day range
- $1.91 to $2.05
- 52-week range
- $1.56 to $3.85
- Average volume
- –
- Previous close
- $1.94
Earnings
next estimate $-0.1400Next report
Dec 2025
+5.9%
Mar 2026
-6.3%
Jun 2026
-28.6%
Sep 2026
-14.3%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $10.0k | $14.0k | $30.0k | $42.0k |
| Gross profit | -$32.0k | -$28.0k | -$20.0k | -$19.0k |
| Operating income | -$8.95m | -$9.36m | -$10.00m | -$8.89m |
| Net income | -$7.88m | -$8.40m | -$9.14m | -$8.05m |
Last four quarters: revenue $96.0k, margin -34866.7%, free cash flow -$28.99m
News
8 latest- Sera Prognostics (SERA) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 days ago
- Sera Prognostics Reports Third Quarter 2026 Financial ResultsFintel · Nov 5, 2026
- What Sera Prognostics (SERA) Said on Its Q3 Earnings CallMarketBeat · Nov 4, 2026
- Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue EstimatesZacks · Nov 4, 2026
- Sera Appoints Scott Gleason As CFO, Focuses On PreTRM Test Expansion RTTNews · Aug 19, 2026
- Sera (SERA) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 19, 2026
- Sera Prognostics Q2 Earnings Call HighlightsMarketBeat · Aug 12, 2026
- Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Misses Revenue EstimatesZacks · Aug 12, 2026
The company
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy information to improve the health of mothers and newborns, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is headquartered in Salt Lake City, Utah.
- Sector
- Health Care
- Industry
- Medical Specialities
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- seraprognostics.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.